The present protocol describes a method to deliver drugs and gene expression-modifying agents perivascularly in an in utero developing fetus. Importantly, the effect of drugs/agents on blood flow can be measured with the progression of pregnancy.
The ability of an organism to maintain a constant blood flow to the brain in response to sudden surges in systemic blood pressure (BP) is known as cerebral autoregulation (CAR), which occurs in the carotid artery. In contrast to full-term neonates, preterm neonates are unable to reduce the cerebral blood flow (CBF) in response to increased systemic BP. In preterm neonates, this exposes the fragile cerebral vessels to high perfusion pressures, leading to their rupture and brain damage. Ex vivo studies using wire myography have demonstrated that carotid arteries from near-term fetuses constrict in response to the activation of adrenergic alpha1 receptors. This response is blunted in the preterm fetus. Thus, to examine the role of alpha1-AR in vivo, presented here is an innovative approach to determine the effects of drugs on a carotid arterial segment in vivo in an ovine fetus during the developmental progression of gestation. The presented data demonstrate the simultaneous measurement of fetal blood flow and blood pressure. The perivascular delivery system can be used to conduct a long-term study over several days. Additional applications for this method could include viral delivery systems to alter the expression of genes in a segment of the carotid artery. These methods could be applied to other blood vessels in the growing organism in utero as well as in adult organisms.
Birth causes stress to the fetus, and there is a considerable increase in the levels of catecholamine, the major stress hormone1,2. This raises the systemic BP, and if this pressure is transmitted to the fragile brain capillaries via the carotid arteries, this can lead to their rupture3,4,5. Surges in systemic BP are prevented from reaching the brain by the constriction of the carotid arteries in the full-term fetus. However, this mechanism is not developed in the preterm fetus, and this is responsible for the significantly higher likelihood of brain damage in preterm fetuses4,5.
Currently, no suitable method exists to examine the maturation of the pathways involved in regulating the carotid blood flow with developing fetuses. These studies on carotid blood flow and vasoresponsiveness are crucial from both basic science and clinical perspectives. Currently, to determine the molecular pathways involved in the regulation of arterial contractility, the standard method involves isolating the arterial segments postmortem. Then, the experiments are conducted using wire myography to determine the vasocontractility of different pharmacological molecules that define the regulatory pathways involved in arterial contractility6,7. Of note, the ex vivo findings are not able to fully replicate the in vivo environment because of the blood flow regulation upstream and downstream of the carotid artery. Thus, the present study aimed to develop a technique that can determine the effects of vasoresponsive chemicals or agents on blood flow in an artery in vivo.
The perivascular delivery methodology described in this article provides an in vivo approach to study the effect of the pharmacological or genetic manipulation of signaling pathways on different arterial segments. Using this method, one can manipulate the fetal blood pressure and carotid blood flow. Additionally, experiments with sheep fetuses are demonstrated for studying the effects of signaling molecules in a developing fetus. Hopefully, the detailed methodology provided will lead to new investigations in the field of blood flow studies, especially in relation to fetal physiology and pathology.
For the present study, approval for the animal experiments was obtained from the Animal Care and Use Committee of the University of Arizona. One time-mated, pregnant Columbia-Rambouillet ewes between 2-4 years of age were used for the present study. The animals were obtained from the University of Arizona Sheep Unit.
1. Animal maintenance
2. Material preparation
3. Presurgical animal preparation
4. Surgical procedure
5. Placing the fetus back and closing the wound
6. Post-operative in vivo experiments
To examine the localized in vivo manipulation of blood flow, 1 mL of phenylephrine (10 µM), an α1-AR agonist, was administered into the perivascular space of the carotid artery by an exteriorized infusion catheter to determine the effect on the local carotid blood flow and the effect on the systemic blood pressure. Figure 1A demonstrates a significant reduction in carotid blood flow without any effect on systemic blood pressure in near-term fetal sheep. Figure 1B shows the same data for a preterm fetus. Administering 1 mL of PHE by the IV route increased the systemic blood flow without affecting the carotid blood flow in near-term fetal sheep (Figure 1C). Figure 1D shows the same data for a preterm fetus. In contrast, the administration of PHE by a perivascular catheter did not have any effect in preterm sheep; however, administration by the intravenous route caused a significant increase in both the carotid blood flow and systemic BP. This experiment demonstrates a fully functional perivascular sleeve that can regulate blood flow in the carotid artery in utero without affecting the systemic BP. The results show that preterm fetuses are not responsive to phenylephrine-mediated carotid blood flow regulation; however, the response is mature in near-term fetuses (Figure 1E). Importantly, the IV administration of PHE increased the carotid blood flow only in preterm fetuses, with no significant effect in near-term fetuses (Figure 1G). However, the IV administration of PHE raised the systemic blood pressure in both preterm and near-term fetuses (Figure 1H). The results also demonstrate that the perivascular instillation of phenylephrine had no effect on the systemic blood pressure (Figure 1F).
Figure 1: In vivo manipulation of blood flow. An exemplary trace of systemic blood pressure and carotid artery blood flow baseline measurements and changes following the administration of phenylephrine (PHE) through the perivascular catheter from (A) an in utero near-term fetus and (B) an in utero preterm fetus. An exemplary trace of systemic blood pressure and carotid artery blood flow baseline measurements and changes following the intravenous administration of phenylephrine (PHE) from (C) an in utero near-term fetus and (D) an in utero preterm fetus. The changes in the (E) percentage of carotid blood flow and (F) systemic blood pressure via the perivascular catheter delivery system for near-term and preterm sheep are shown. The changes in the (G) percentage of carotid blood flow and (H) systemic blood pressure via systemic administration for near-term and preterm sheep are shown. The error bars demonstrate the standard error of the mean. N = 4 in each group. *P < 0.05 by a Student's t-test. Please click here to view a larger version of this figure.
Currently, no method exists to examine vessel contractility and dilatation in vivo in response to drug compounds and gene manipulation. As a standard in the field, in vivo blood flow is measured by Doppler flow probes, microspheres, and radioactive molecules such as tritiated water. However, to manipulate the receptors’ functions or downstream signaling, the animals are sacrificed, and experiments are conducted in vitro in organ baths following the isolation of arterial segments. The current methods provide a way to conduct in vivo manipulations of arterial segments by introducing chemicals or vectors to modify gene expression. Furthermore, this method has a minimal effect on systemic circulation because of the local delivery of the agents.
The current experiments demonstrate that the administration of phenylephrine results in the constriction of the carotid artery with a reduction in blood flow. The above investigation elucidates the role of alpha-adrenergic receptors in regulating the carotid artery blood flow to the brain. This technique can be used to examine the effect of different pharmacological compounds on blood flow in real-time in live fetuses. The perivascular catheter can also be used to instill lentivirus in the perivascular space, which is taken up by the vasculature, to result in the knockdown or overexpression of the desired signaling protein or receptor.
For decades, organ and tissue baths have provided useful data regarding vessel contractility6,8,9. However, these studies are ex vivo, which raises questions regarding the reproducibility in vivo and means continuous measurements cannot be performed. To overcome this limitation, this innovative approach examines carotid artery blood flow in vivo. An additional advancement in this methodology will include the adoption of genetic modulation using virus delivery approaches, which will allow arterial segments to be genetically altered to upregulate and downregulate gene expression by delivering shRNA or CRISPR/Cas9.
The critical step in the protocol is placing the perivascular catheter parallel to the vessel in close proximity. For this to work, one needs to know the diameter of the targeted artery. Additionally, developing a proper sleeve is important. One may place the sleeve adjacent to the artery to be modulated instead of surrounding it. This will also provide local delivery of the chemicals and targeting agents.
The limitation of the method is that it only regulates a segment of the artery, and the results regarding organ or tissue blood flow should be interpreted carefully. One may be required to change the length of the sleeve and the amount of chemicals to achieve the desired effect. The method has wide applications in modulating gene regulation in live fetuses. This can be adapted to modulate gene function and expression in a portion of any tissue. Additionally, the method can be applied to modulate gene expression in an adult organism.
Although there are other methods to measure in vivo blood flow, such as using transonic flow probes10, laser Doppler11, and microspheres12, none of those methods allow for examining the local effect of the drugs on the blood flow in the arterial segment as opposed to the systemic effects of the intervention. Thus, the current method is unique, as it can measure and modulate the local blood flow without any systemic effects.
The authors have nothing to disclose.
Intramural funds from the University of Arizona were used for these studies.
Aaron Bovie Electrosurgical Cautery | Henry Schein, Inc | 5905974 | |
Aaron Bovie Electrosurgical Generator | Henry Schein, Inc | 1229913 | |
Alfalfa Pellets | Sacate Pellet Mills, Inc. Maricopa AZ | 100-80 | |
Analog to Digital Converter | ADI Instruments | Powerlab | |
Babcock forceps | Roboz Surgicals | RS8020 | |
Bridge Amplifier | ADI Instruments | Bridge Amplifier | |
Castroviejo scissors | Roboz Surgicals | RS5650SC | |
Diazepam | Henry Schein, Inc | 1278188 | |
Endotracheal Tube | Henry Schein, Inc | 7020408 | |
Flow Probes | Transonic Systems Inc. | MC2PSS-JS-WC100-CRS10-GC, MC3PSS-LS-WC100-CRS10-GC | |
Heparin | Henry Schein, Inc | 1162406 | |
Isoflurane | Henry Schein, Inc | 1182097 | |
Ketamine | Henry Schein, Inc | 1273383 | |
Ketoprofen | Zoetis Inc., Kalamazoo, MI | Ketofen | |
Manifold Pump Tubing | Fisher Scientific | 14-190-508 | |
Metzenbaum scissors | Roboz Surgicals | RS6010 | |
Narkomed 4 Anesthesia Machine | North American Dräger | Narkomed 4 | |
Normal Saline | Fisher Scientific | Z1376 | |
penicillin G procaine suspension | Henry Schein, Inc | 7455874 | |
phenylbutazone | VetOne Boise, ID | 510226 | |
Phenylephrine | Sigma Aldrich Inc. | P1240000 | |
Pivodine Scrub | VetOne | 510094 | Germicidal cleanser |
PowerLab | ADInstruments | Data acquisition hardware device | |
Pulse Oximeter | Amazon Inc. | UT100V | |
Tygon Tubing | Fisher Scientific | ND-100-80 | |
V-Top Surgical Table | VetLine Veterinary Classic Surgery | TSP-4010 | |
Wound Clips | Fisher Scientific | 10-001-024 |